131 related articles for article (PubMed ID: 32378637)
1. [Cardio-oncology - elucidation of the mechanism of cardiac dysfunction caused by cancer therapy and cancer cachexia].
Nonaka M; Ueno S; Uezono Y
Nihon Yakurigaku Zasshi; 2020; 155(3):165-170. PubMed ID: 32378637
[TBL] [Abstract][Full Text] [Related]
2. Megestrol acetate improves cardiac function in a model of cancer cachexia-induced cardiomyopathy by autophagic modulation.
Musolino V; Palus S; Tschirner A; Drescher C; Gliozzi M; Carresi C; Vitale C; Muscoli C; Doehner W; von Haehling S; Anker SD; Mollace V; Springer J
J Cachexia Sarcopenia Muscle; 2016 Dec; 7(5):555-566. PubMed ID: 27239419
[TBL] [Abstract][Full Text] [Related]
3. The pathogenesis and treatment of cardiac atrophy in cancer cachexia.
Murphy KT
Am J Physiol Heart Circ Physiol; 2016 Feb; 310(4):H466-77. PubMed ID: 26718971
[TBL] [Abstract][Full Text] [Related]
4. New cancer cachexia rat model generated by implantation of a peritoneal dissemination-derived human stomach cancer cell line.
Terawaki K; Sawada Y; Kashiwase Y; Hashimoto H; Yoshimura M; Suzuki M; Miyano K; Sudo Y; Shiraishi S; Higami Y; Yanagihara K; Kase Y; Ueta Y; Uezono Y
Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E373-87. PubMed ID: 24347053
[TBL] [Abstract][Full Text] [Related]
5. How progressive cancer endangers the heart: an intriguing and underestimated problem.
Ausoni S; Calamelli S; Saccà S; Azzarello G
Cancer Metastasis Rev; 2020 Jun; 39(2):535-552. PubMed ID: 32152913
[TBL] [Abstract][Full Text] [Related]
6. Tandospirone reduces wasting and improves cardiac function in experimental cancer cachexia.
Elkina Y; Palus S; Tschirner A; Hartmann K; von Haehling S; Doehner W; Mayer U; Coats AJ; Beadle J; Anker SD; Springer J
Int J Cardiol; 2013 Dec; 170(2):160-6. PubMed ID: 24207070
[TBL] [Abstract][Full Text] [Related]
7. Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model.
Terawaki K; Kashiwase Y; Sawada Y; Hashimoto H; Yoshimura M; Ohbuchi K; Sudo Y; Suzuki M; Miyano K; Shiraishi S; Higami Y; Yanagihara K; Hattori T; Kase Y; Ueta Y; Uezono Y
PLoS One; 2017; 12(3):e0173113. PubMed ID: 28249026
[TBL] [Abstract][Full Text] [Related]
8. Cardiac alterations in cancer-induced cachexia in mice.
Tian M; Nishijima Y; Asp ML; Stout MB; Reiser PJ; Belury MA
Int J Oncol; 2010 Aug; 37(2):347-53. PubMed ID: 20596662
[TBL] [Abstract][Full Text] [Related]
9. Cardiac muscle wasting in individuals with cancer cachexia.
Barkhudaryan A; Scherbakov N; Springer J; Doehner W
ESC Heart Fail; 2017 Nov; 4(4):458-467. PubMed ID: 29154433
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.
Bernardo B; Joaquim S; Garren J; Boucher M; Houle C; LaCarubba B; Qiao S; Wu Z; Esquejo RM; Peloquin M; Kim H; Breen DM
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1813-1829. PubMed ID: 32924335
[TBL] [Abstract][Full Text] [Related]
11. Minocycline attenuates cardiac dysfunction in tumor-burdened mice.
Devine RD; Eichenseer CM; Wold LE
J Mol Cell Cardiol; 2016 Nov; 100():35-42. PubMed ID: 27663174
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Trobec K; Palus S; Tschirner A; von Haehling S; Doehner W; Lainscak M; Anker SD; Springer J
Nutrition; 2014 Sep; 30(9):1069-75. PubMed ID: 24976415
[TBL] [Abstract][Full Text] [Related]
13. Exercise training delays cardiac remodeling in a mouse model of cancer cachexia.
Fernandes LG; Tobias GC; Paixão AO; Dourado PM; Voltarelli VA; Brum PC
Life Sci; 2020 Nov; 260():118392. PubMed ID: 32898523
[TBL] [Abstract][Full Text] [Related]
14. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
[TBL] [Abstract][Full Text] [Related]
15. Cancer-induced cardiac cachexia: Pathogenesis and impact of physical activity (Review).
Belloum Y; Rannou-Bekono F; Favier FB
Oncol Rep; 2017 May; 37(5):2543-2552. PubMed ID: 28393216
[TBL] [Abstract][Full Text] [Related]
16. Preventive effects of low-intensity exercise on cancer cachexia-induced muscle atrophy.
Tanaka M; Sugimoto K; Fujimoto T; Xie K; Takahashi T; Akasaka H; Kurinami H; Yasunobe Y; Matsumoto T; Fujino H; Rakugi H
FASEB J; 2019 Jul; 33(7):7852-7862. PubMed ID: 30916585
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia, cachexia and congestive heart failure in the elderly.
Zamboni M; Rossi AP; Corzato F; Bambace C; Mazzali G; Fantin F
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):58-67. PubMed ID: 23369138
[TBL] [Abstract][Full Text] [Related]
18. Aerobic exercise training as therapy for cardiac and cancer cachexia.
Alves CR; da Cunha TF; da Paixão NA; Brum PC
Life Sci; 2015 Mar; 125():9-14. PubMed ID: 25500304
[TBL] [Abstract][Full Text] [Related]
19. ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia.
Huot JR; Pin F; Narasimhan A; Novinger LJ; Keith AS; Zimmers TA; Willis MS; Bonetto A
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1779-1798. PubMed ID: 33200567
[TBL] [Abstract][Full Text] [Related]
20. Loss of strength capacity is associated with mortality, but resistance exercise training promotes only modest effects during cachexia progression.
das Neves W; Alves CR; de Almeida NR; Guimarães FL; Ramires PR; Brum PC; Lancha AH
Life Sci; 2016 Oct; 163():11-22. PubMed ID: 27575705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
